MediPharm Labs and Georgian College Complete First Research and Innovation Collaboration Driving Data and Analytics

Ontario, – MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc., has completed work associated with a Research and Innovation Collaboration Agreement with Georgian College for a Data and Analytics Insights project. This four-month applied research projectContinue reading “MediPharm Labs and Georgian College Complete First Research and Innovation Collaboration Driving Data and Analytics”

EnWave Announces 2020 Third Quarter Consolidated Interim Financial Results and Corporate Strategy Update

#ENW Highlights for Q3 Revenue from EnWave in Q3 2020 was $1,609 (expressed in ‘000s) compared to $5,075 in Q3 2019, a decrease of $3,466 or 68%. The decrease in revenue was due to a slowdown in large-scale Radiant Energy Vacuum (“REVTM”) machinery sales primarily to cannabis royalty partners. Reduced company-wide overhead expenses by $1.0Continue reading “EnWave Announces 2020 Third Quarter Consolidated Interim Financial Results and Corporate Strategy Update”

Aleafia Health Announces Appointment of Pharmaceutical Executive Tricia Symmes as Chief Commercial Officer

TORONTO, Aug. 21, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) today announced the appointment of Tricia Symmes as the Company’s Chief Commercial Officer, effective August 27, 2020. Symmes brings over 20 years of experience as a senior executive in the pharmaceutical, consumer packaged goods, and cannabis industries.Continue reading “Aleafia Health Announces Appointment of Pharmaceutical Executive Tricia Symmes as Chief Commercial Officer”

Rapid Dose Therapeutics Announces Cease Trade Order Due to Delay in Annual Filings Under COVID-19 Duress

Ontario, Aug. 20, 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) announces that, due to circumstances beyond its control created by and relating to the COVID-19 pandemic, the Company was not able to file its audited financial statements and management discussion and analysis for the year ended February 29, 2020 together with officers’ certificates relating theretoContinue reading “Rapid Dose Therapeutics Announces Cease Trade Order Due to Delay in Annual Filings Under COVID-19 Duress”

Indiva Secures Agreement With CannMart

Indiva’s CBD Softgels and Indica Capsules available on CannMart by the end of August; Bhang® Chocolate and Wana™ Sour Gummies to follow Ontario, – Indiva Limited (TSXV:NDVA) (OTCQX:NDVAF), a leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its wholly owned subsidiary, Indiva Inc., has reached an agreement with CannMart Inc.Continue reading “Indiva Secures Agreement With CannMart”

The Valens Company Granted Health Canada Research Licence to Conduct Human Administration Trials for Sensory and Taste Evaluation of Products

KELOWNA – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced that it has received its Cannabis Research Licence under Health Canada’s Cannabis Act and Cannabis Regulations through its wholly-owned subsidiary, Valens Agritech Ltd. This licence permits The Valens Company to conduct research involvingContinue reading “The Valens Company Granted Health Canada Research Licence to Conduct Human Administration Trials for Sensory and Taste Evaluation of Products”

PSYC (“Global Trac Solutions, Inc.”)Establishes New Partnership with Industry Leader, Microdose Psychedelic Insights

“We are delighted to have established this outstanding partnership with a firm like Microdose who have such a compelling and impressive finger on the pulse of the medicinal psychedelic industry.” LAS VEGAS,- Global Trac Solutions, Inc. (OTCPink: PSYC) is pleased to announce that in an effort to accelerate the Company’s development of premium industry centricContinue reading “PSYC (“Global Trac Solutions, Inc.”)Establishes New Partnership with Industry Leader, Microdose Psychedelic Insights”

Canopy Rivers Announces AGM Date

TORONTO, Aug. 18, 2020 – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) will hold its annual general and special meeting of shareholders of the Company (“Shareholders“) on September 24, 2020 at 10 a.m. (EDT). Electronic copies of all materials related to the Meeting can be found on the Company’s profile on the System for Electronic Document Analysis and Retrieval orContinue reading “Canopy Rivers Announces AGM Date”

Aleafia Health Announces Second Quarter 2020 Results

“Our significant increase in medical cannabis sales and patient growth, coupled with much needed Cannabis 2.0 formats and dried flower products will see us continue to capture market in both the medical and adult-use markets.” CEO Geoffrey Benic Highlights $57.0M cash, cash equivalents and freely tradeable marketable securities $3.0 million positive adjusted EBITDA 44% increaseContinue reading “Aleafia Health Announces Second Quarter 2020 Results”